In financial year 2023, in India, GSK Pharmaceuticals Limited spent approximately 79 million Indian rupees on the non-ongoing project related to the corporate social responsibility (CSR). Nearly 71 million Indian rupees was spent on donations of Albendazole, a medication used in the effort to eradicate Lymphatic Filariasis. In financial year 2023, GSK ranked as the leading brand in the anti-infectives and dermatology segment.
Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited other than ongoing projects in India during financial year 2023, by expense (in million Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you GlaxoSmithKline Pharmaceuticals Limited India
Market overview
6
- Premium Statistic Revenue of the OTC pharmaceuticals in selected countries worldwide
- Basic Statistic Top pharma companies worldwide by number of originated drugs 2024
- Premium Statistic Annual revenue of Indian pharmaceutical market 2015-2030
- Premium Statistic Distribution of therapies in Indian pharmaceuticals 2022
- Premium Statistic Share of pharmacy in organized retail India FY 2020-2022
- Premium Statistic Leading pharmaceutical and drug companies India 2023, by market capitalization
GSK India - key figures
6
- Premium Statistic GSK's revenue by region 2013-2023
- Premium Statistic GSK's number of employees by region 2011-2023
- Premium Statistic GSK Pharmaceuticals' number of employees in India FY 2016-2023
- Premium Statistic GSK Pharmaceuticals' operation revenue in India FY 2014-2023
- Premium Statistic GSK Pharmaceuticals' EBITDA in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' net profit India FY 2015-2023
Product portfolio
3
Main competitiors
4
Further related statistics
10
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Expenditure worldwide on diabetes by market 2013-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Banco Santander global operations: geographic diversification of profit 2023
- Johnson & Johnson's number of employees 2004-2023
Further Content: You might find this interesting as well
Statistics
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Expenditure worldwide on diabetes by market 2013-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- MorphoSys' revenue 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Banco Santander global operations: geographic diversification of profit 2023
- Johnson & Johnson's number of employees 2004-2023
GlaxoSmithKline. (June 17, 2023). Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited other than ongoing projects in India during financial year 2023, by expense (in million Indian rupees) [Graph]. In Statista. Retrieved June 11, 2024, from https://www.statista.com/statistics/1249480/india-gsk-pharmaceuticals-additional-csr-expenditure/
GlaxoSmithKline. "Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited other than ongoing projects in India during financial year 2023, by expense (in million Indian rupees)." Chart. June 17, 2023. Statista. Accessed June 11, 2024. https://www.statista.com/statistics/1249480/india-gsk-pharmaceuticals-additional-csr-expenditure/
GlaxoSmithKline. (2023). Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited other than ongoing projects in India during financial year 2023, by expense (in million Indian rupees). Statista. Statista Inc.. Accessed: June 11, 2024. https://www.statista.com/statistics/1249480/india-gsk-pharmaceuticals-additional-csr-expenditure/
GlaxoSmithKline. "Corporate Social Responsibility Expenditure of Gsk Pharmaceuticals Limited Other than Ongoing Projects in India during Financial Year 2023, by Expense (in Million Indian Rupees)." Statista, Statista Inc., 17 Jun 2023, https://www.statista.com/statistics/1249480/india-gsk-pharmaceuticals-additional-csr-expenditure/
GlaxoSmithKline, Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited other than ongoing projects in India during financial year 2023, by expense (in million Indian rupees) Statista, https://www.statista.com/statistics/1249480/india-gsk-pharmaceuticals-additional-csr-expenditure/ (last visited June 11, 2024)
Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited other than ongoing projects in India during financial year 2023, by expense (in million Indian rupees) [Graph], GlaxoSmithKline, June 17, 2023. [Online]. Available: https://www.statista.com/statistics/1249480/india-gsk-pharmaceuticals-additional-csr-expenditure/